[8-K] Kewaunee Scientific Corp Reports Material Event

Rhea-AI Filing Summary

Kewaunee Scientific (Nasdaq: KEQU) filed a Form 8-K on June 25 2025 to furnish Item 2.02 – Results of Operations and Financial Condition. The company released its fourth-quarter and fiscal-year results for the period ended April 30 2025 via a press release, attached as Exhibit 99.1.

The information is expressly treated as "furnished," not "filed," thereby avoiding Section 18 liability and limiting incorporation into future SEC documents unless specifically cited. No other reportable events were disclosed.

Insights

Financial Analyst

TL;DR: Earnings data released; market impact hinges on unavailable figures.

The 8-K signals the end-of-year reporting cycle and gives investors the first look at Q4 and FY25 performance ahead of the 10-K. Although the filing omits hard numbers, Item 2.02 filings typically move the stock if results diverge from expectations. The "furnished" status means limited legal exposure but equal informational value. Key next steps for investors are to examine Exhibit 99.1 for revenue trends, margin trajectory and backlog commentary, then compare to prior guidance. Because no guidance revision, cash-flow detail or strategic update is mentioned, I classify the disclosure as informational rather than directional.

Corporate Disclosure Specialist

TL;DR: Routine results announcement; no governance or compliance flags.

From a disclosure-quality perspective, the company used the standard Item 2.02 route, separating the press release from "filed" status to contain potential liability. No additional items—such as impairments, restatements, or management changes—were triggered, implying no immediate red-flags. The inclusion of Inline XBRL on the cover meets current SEC mandates. Investors should note that absence of other items suggests operational stability, but absence of figures in the 8-K limits immediate assessment of performance or risk. Overall effect on valuation remains undetermined until Exhibit 99.1 is reviewed.

FALSE000005552900000555292025-06-252025-06-25

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 25, 2025

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

Delaware

0-5286

38-0715562

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(IRS Employer Identification No.)

2700 West Front Street

Statesville, NC 28677

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

N/A

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $2.50 par value

KEQU

The Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On June 25, 2025, Kewaunee Scientific Corporation issued a press release announcing financial results for its fourth quarter and its fiscal year ended April 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press Release of Kewaunee Scientific Corporation dated June 25, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

						KEWAUNEE SCIENTIFIC CORPORATION                              (Registrant)
Date: June 25, 2025						By			/s/ Donald T. Gardner III
									Donald T. Gardner III
									Vice President, Finance
									Chief Financial Officer